methylprednisolone has been researched along with Delayed Graft Function in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Gibson, IW; Ho, J; Nickerson, PW; Rampersad, C; Rush, DN; Shaw, J; Wiebe, C | 1 |
Bułanowski, M; Dębska-Ślizień, A; Rutkowski, B; Tarasewicz, A; Więcek, A | 1 |
Benck, U; Krämer, BK; Mundt, HM; Schnülle, P; Yard, BA | 1 |
Alper, AB; Atiq, M; Buell, J; Killackey, M; Lee, B; Liu, Y; Paramesh, A; Qin, H; Simon, E; Umber, A; Zhang, R | 1 |
Daher, EF; Esmeraldo, RM; Libório, AB; Mendoza, TR; Oliveira, ML; Paes, FJ; Silva Junior, GB | 1 |
Fujiwara, M; Hashimoto, S; Koike, T; Satoh, N; Takenouchi, S | 1 |
1 review(s) available for methylprednisolone and Delayed Graft Function
Article | Year |
---|---|
Optimized donor management and organ preservation before kidney transplantation.
Topics: Acetylcysteine; Animals; Antioxidants; Brain Death; Deamino Arginine Vasopressin; Delayed Graft Function; Dopamine; Graft Survival; Humans; Immune System; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone; Organ Preservation; Randomized Controlled Trials as Topic; Recombinant Proteins; Resuscitation; Superoxide Dismutase; Thyroid Hormones; Tissue and Organ Procurement; Tissue Donors | 2016 |
1 trial(s) available for methylprednisolone and Delayed Graft Function
Article | Year |
---|---|
Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Basiliximab; Cohort Studies; Daclizumab; Delayed Graft Function; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Induction Chemotherapy; Kaplan-Meier Estimate; Kidney Transplantation; Lymphocyte Depletion; Male; Methylprednisolone; Multivariate Analysis; Proportional Hazards Models; Receptors, Interleukin-2; Recombinant Fusion Proteins; Retrospective Studies; Sex Factors; Time Factors | 2011 |
4 other study(ies) available for methylprednisolone and Delayed Graft Function
Article | Year |
---|---|
Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report.
Topics: Antibodies; Antilymphocyte Serum; Delayed Graft Function; Glomerulonephritis, IGA; Glucocorticoids; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Plasmapheresis; Vimentin; Young Adult | 2020 |
Everolimus in immunosuppressive treatment after kidney transplantation in a patient with tuberous sclerosis: case report.
Topics: Adult; Creatinine; Delayed Graft Function; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis | 2014 |
A comparison of three induction therapies on patients with delayed graft function after kidney transplantation.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Basiliximab; Chi-Square Distribution; Delayed Graft Function; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Induction Chemotherapy; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Logistic Models; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Switching of donor cells after urgent second cord blood transplantation for suspected graft failure.
Topics: Adult; Anti-Inflammatory Agents; Bone Marrow; Cord Blood Stem Cell Transplantation; Delayed Graft Function; Donor Selection; Female; Ferritins; Graft Survival; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Macrophages; Methylprednisolone; Myeloablative Agonists; Tissue Donors; Transplantation Conditioning; Vascular Diseases; Vidarabine | 2007 |